Tags: Drug.

Satavaptan (INN; codenamed SR121463 planned tradename Aquilda) is a vasopressin-2 receptor antagonist undergoing research for the treatment of hyponatremia. It is also being studied for the treatment of ascites.It was developed by Sanofi-Aventis. As of 2008 it is under regulatory review in the European Union.

Satavaptan_structure.svg
ATC prefix
none
CAS number
185913-78-4
FDA UNII code
AJS8S3P31H
IUPAC name
N-(tert-butyl)-4-[(1s4s)-5'-ethoxy-4-(2-morpholin-4-ylethoxy)-2'-oxospiro[cyclohexane-13'-indol]-1'(2'H)-yl]sulfonyl-3-methoxybenzamide
PubChem
9810773

Loading...

This page contains content from the copyrighted Wikipedia article "Satavaptan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.